hotspot -WSS

hotspot

author：knowledge 2025-09-30 20:18:37 - browse：943

Tortoise and hare — Medical devices have historically been seen as having faster paths to market than their pharmacological counterparts. The growing requirement for cost-effectiveness trials may be slowing them down. Jonathan Elderfield/AP

When a colleague and I started our medical device company in 2009, we were in our second year at Harvard Medical School. Some classmates joked that they would still be in residency by the time we had moved on to our next big idea. We knew better — we expected it to be a long haul. Eight years into our journey, thousands of individuals have used our product in countries where it has been approved. But we have yet to gain approval in the U.S. — a long and expensive process.

In 2016, the United States Food and Drug Administration approved 22 new drugs, down from 45 approvals in 2015. The decline in drug discovery has been attributed to a variety of factors that include ballooning research and development expenses (the cost to develop a new drug is now estimated to be more than $2.5 billion), high rates of failure (a whopping 90 percent of Phase 1 candidates never make it to launch), and the complexity of human biology, which can thwart even the most promising candidates.

Medical devices have historically been viewed as having faster and lower-cost paths to market than their pharmacological counterparts: the average cost to develop high-risk, novel medical devices is estimated to be $94 million. After all, device engineers can leverage lower-cost animal models further into development than their pharmaceutical colleagues, the human clinical trials necessary for FDA approval are often smaller in scale, and, in some cases, expenses can be defrayed by revenue generated outside the United States in markets with faster regulatory pathways.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 3 killed, 8 injured in late

WSS

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

NASA releases new images of 'fingerprint

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

1 dead, 9 hurt in July 4th fireworks explosion

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Wikipedia

hotspot

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

23andMe had bad news about my health. I wish a person had delivered it

10 states plan to sue EPA over standards for residential wood

Trump demands the U.S. pay no more for drugs than other countries … again

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Bright Health sells Medicare Advantage business to Molina

With fresh data, a dynamic duo powers Eli Lilly to new heights

hotspot

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

How redistricting in 6 states could affect who controls Congress

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

10 states plan to sue EPA over standards for residential wood

US intelligence assessment says Iran not currently developing nuclear weapons

Drinking water from half of US faucets contains PFAS: Study

leisure time

hotspot

Wikipedia

focus